Reported results
- Revenue was $25.8 million, up 48% year-over-year.
- Annual Contract Value (ACV) plus royalties was $103.8 million, up 39% year-over-year.
- Operating loss was $11.3 million, compared to an operating loss of $8.7 million in the third quarter of 2025.
- Non-GAAP operating loss was $1.2 million, compared to a Non-GAAP operating loss of $3.5 million in the third quarter of 2025.
- Net loss was $11.2 million or $0.23 per share.
- Non-GAAP net loss was $1.1 million or $0.02 per share.
Guidance
- For the fourth quarter of 2026, Arteris expects ACV + royalties of $103.0 million to $107.0 million, revenue of $25.7 million to $26.7 million, and Non-GAAP operating (loss) income of $(0.9) million to $1.1 million.
- For full year 2026, Arteris expects ACV + royalties of $103.0 million to $107.0 million, revenue of $98.5 million to $99.5 million, Non-GAAP operating (loss) income of $(9.2) million to $(7.2) million, and free cash flow of $5.0 million to $9.0 million.
Price and volatility reaction
The stock moved +11.7% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved +6.2 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 15.93 | 2026-11-05 |
| Close after release | 17.8 | 2026-11-06 |
| Realised move | +11.7% | close to close |
| 30d ATM IV change | +6.2 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.
